US FDA authorises Pfizer COVID-19 vaccine booster for children ages 12 to 15

Jan 04, 2022, 09:20 AM(IST) WION Video Team

The US Food and Drug Administration has authorised the use of a third dose of the Pfizer-BioNTech's COVID-19 vaccine for children ages 12 to 15, and reduced the wait time between initial vaccination and an extra dose from six months to five months for all ages.

Read in App